You are not currently logged in.
Access JSTOR through your library or other institution:
Control of Vancomycin‐Resistant Enterococci in the Neonatal Intensive Care Unit
Nalini Singh , MD, MPH, Marie‐Michèle Léger , PA‐C, MPH, Joyce Campbell , RN, MS, Billie Short , MD and Joseph M. Campos , PhD
Infection Control and Hospital Epidemiology
Vol. 26, No. 7 (July 2005), pp. 646-649
Published by: Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Stable URL: http://www.jstor.org/stable/10.1086/502595
Page Count: 4
You can always find the topics here!Topics: Infections, Patient surveillance, Infants, Neonatal intensive care units, Epidemiology, Disease transmission, Infection control, Pediatrics, Bays, DNA
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
BACKGROUND AND OBJECTIVE. Multidrug‐resistant organisms (MDROs), such as vancomycin‐resistant enterococci (VRE), cause serious infections, especially among high‐riskpatients in NICUs. When VRE was introduced and transmitted in our NICU despite recommended infection control practices, we instituted active surveillance cultures to determine their efficacy in detecting and controlling spread of VRE among high‐risk infants. METHODS. Active surveillance cultures, other infection control measures, and a mandatory in‐service education module on preventing MDRO transmission were implemented. Cultures were performed on NICU admission and then weekly during their stay. Molecular DNA fingerprinting of VRE isolates facilitated targeting efforts to eliminate clonal spread of VRE. Repetitive sequence PCR (rep‐PCR)–based DNA fingerprinting was used to compare isolates recovered from patients with VRE infection or colonization. Environmental VRE cultures were performed around VRE‐colonized or ‐infected patients. DNA fingerprints were prepared from the products of rep‐PCR amplification and analyzed using software to determine strain genetic relatedness. RESULTS. Active surveillance cultures identified 65 patients with VRE colonization or infection among 1,820 admitted to the NICU. Rep‐PCR performed on 60 VRE isolates identified 3 clusters. Cluster 1 included isolates from 21 patients and 4 isolates from the environment of the index patient. Clusters 2 and 3 included isolates from 23 and 3 patients, respectively. Similarity coefficients among the members of each cluster were 95% or greater. CONCLUSIONS. Control of transmission of multi‐clonal VRE strains was achieved. Active surveillance cultures, together with implementation of other infection control measures, combined with rep‐PCR DNA fingerprinting were instrumental in controlling VRE transmission in our NICU.
© 2005 by The Society for Healthcare Epidemiology of America. All rights reserved.